Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure Prophylaxis.
作者信息
Ibrahim Mustafa E, Glidden David V, Grant Robert M, Anderson Peter L
机构信息
Department of Pharmaceutical Sciences and Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
University of California San Francisco, San Francisco, California, USA.
出版信息
AIDS Res Hum Retroviruses. 2021 Jun;37(6):407-408. doi: 10.1089/AID.2021.0032.
Abstract
摘要
相似文献
1
Revisiting the Pharmacological Forgiveness of HIV Pre-Exposure Prophylaxis.重新审视HIV暴露前预防的药理学赦免作用。
AIDS Res Hum Retroviruses. 2021 Jun;37(6):407-408. doi: 10.1089/AID.2021.0032.
2
Failure of on-demand pre-exposure prophylaxis: the risk of HIV drug resistance.按需暴露前预防失败：HIV耐药风险
Sex Transm Infect. 2022 May;98(3):234. doi: 10.1136/sextrans-2021-055354. Epub 2022 Jan 17.
3
Transitioning from HIV post-exposure prophylaxis to pre-exposure prophylaxis in men who have sex with men.男男性行为者从艾滋病病毒暴露后预防过渡到暴露前预防
HIV Med. 2021 Sep;22(8):780-781. doi: 10.1111/hiv.13112. Epub 2021 Apr 30.
4
The Path to Implementation of HIV Pre-exposure Prophylaxis for People Involved in Criminal Justice Systems.为刑事司法系统相关人员实施艾滋病毒暴露前预防的途径。
Curr HIV/AIDS Rep. 2018 Apr;15(2):93-95. doi: 10.1007/s11904-018-0389-9.
5
Pre-exposure prophylaxis for HIV: effective and underused.HIV暴露前预防：有效但未得到充分利用。
CMAJ. 2022 Sep 6;194(34):E1164-E1170. doi: 10.1503/cmaj.220645.
6
More pre-exposure prophylaxis for rising HIV infection?针对不断上升的艾滋病毒感染增加暴露前预防措施？
AIDS Rev. 2014 Apr-Jun;16(2):118-9.
7
Updates in pre-exposure prophylaxis for HIV.HIV暴露前预防的进展
Lancet Infect Dis. 2022 Mar;22(3):320. doi: 10.1016/S1473-3099(22)00081-0.
8
Reaching the full preventive potential of HIV pre-exposure prophylaxis.充分发挥HIV暴露前预防的预防潜力。
Lancet Public Health. 2022 Jun;7(6):e488-e489. doi: 10.1016/S2468-2667(22)00116-5.
9
Has Pre-exposure Prophylaxis Made a Difference at a Population Level? Jury Is Still Out.暴露前预防在人群层面上有作用吗？尚无定论。
Clin Infect Dis. 2020 Dec 15;71(12):3152-3153. doi: 10.1093/cid/ciz1236.
10
Pre-exposure prophylaxis for HIV: A powerful preventive tool still underused.艾滋病病毒暴露前预防：一种强大的预防工具仍未得到充分利用。
Med Clin (Barc). 2020 May 8;154(9):348-350. doi: 10.1016/j.medcli.2019.10.007. Epub 2019 Nov 22.
引用本文的文献
1
Usability and effectiveness of adherence monitoring of a mobile app designed to monitor and improve adherence to event-driven and daily HIV pre-exposure prophylaxis among men who have sex with men in Taiwan.一款旨在监测和提高台湾男男性行为者对事件驱动型及每日艾滋病病毒暴露前预防药物依从性的移动应用程序，其依从性监测的可用性和有效性。
Digit Health. 2022 May 22;8:20552076221102770. doi: 10.1177/20552076221102770. eCollection 2022 Jan-Dec.
本文引用的文献
1
Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis.HIV 暴露前预防用药的个体化依从性基准
AIDS Res Hum Retroviruses. 2021 Jun;37(6):421-428. doi: 10.1089/AID.2020.0108. Epub 2020 Dec 10.
2
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.按需暴露前预防治疗用于男男性行为人群的有效性、安全性和对性行为影响的观察性队列研究。
Lancet HIV. 2017 Sep;4(9):e402-e410. doi: 10.1016/S2352-3018(17)30089-9. Epub 2017 Jul 23.
3
A Translational Pharmacology Approach to Predicting Outcomes of Preexposure Prophylaxis Against HIV in Men and Women Using Tenofovir Disoproxil Fumarate With or Without Emtricitabine.一种转化药理学方法，用于预测使用富马酸替诺福韦二吡呋酯联合或不联合恩曲他滨对男性和女性进行暴露前预防艾滋病毒的结果。
J Infect Dis. 2016 Jul 1;214(1):55-64. doi: 10.1093/infdis/jiw077. Epub 2016 Feb 24.
4
Current concepts for PrEP adherence in the PrEP revolution: from clinical trials to routine practice.预防艾滋病病毒暴露前预防革命中关于坚持暴露前预防的当前概念：从临床试验到常规实践。
Curr Opin HIV AIDS. 2016 Jan;11(1):10-7. doi: 10.1097/COH.0000000000000220.
5
Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study.男男性行为者和男变女性别者中暴露前预防措施的采用情况、性行为及艾滋病毒发病率：一项队列研究
Lancet Infect Dis. 2014 Sep;14(9):820-9. doi: 10.1016/S1473-3099(14)70847-3. Epub 2014 Jul 22.
Zotero 插件